A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction

Sixty treatment-seeking individuals with methamphetamine (MA) dependence entered a randomized, placebo-controlled, double-blind clinical trial of oral dextroamphetamine (d-AMP) as a replacement therapy for MA dependence. The subjects took 60 mg sustained-release d-AMP for 8 weeks, during which time...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Galloway, GP, Buscemi, R, Coyle, JR, Flower, K, Siegrist, JD, Fiske, LA, Baggott, MJ, Li, L, Polcin, D, Chen, CYA, Mendelson, J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514554/
https://ncbi.nlm.nih.gov/pubmed/21178989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2010.307
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak